Ponesimod (ACT-128800) | S1P1 Agonist

Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	854107-55-4
Formula :	C₂₃H₂₅ClN₂O₄S
M.W :	460.97
SMILES Code :	O=C1N(C2=CC=CC=C2C)/C(S/C1=C\C3=CC=C(OC[C@H](O)CO)C(Cl)=C3)=N/CCC
Synonyms :	ACT-128800
MDL No. :	MFCD18207776
InChI Key :	LPAUOXUZGSBGDU-ULCCENQXSA-N
Pubchem ID :	11363176

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335
Precautionary Statements:	P261-P305+P351+P338

Hela cells	100 nM	4 hours	To evaluate the ability of BSA–RuII(CO)2 complex to release CO in HeLa cells, results showed a significant increase in intracellular fluorescence indicating CO release.	PMC10393615
BV2 cells	10 nM or 100 nM	24 hours	SR9011 inhibited LPS-induced iNOS and COX-2 protein expression	PMC10393615
Mixed glial cells	10 nM or 100 nM	24 hours	Ponesimod prevented the Aβ42-induced increase in TLR4 and S1PR1 levels, as well as the formation of their complex.	PMC10393615
Human primary astrocytes	1 µM	24 or 48 hours	Evaluate the effect of Ponesimod on cytokine-induced gene expression changes. Results showed Ponesimod significantly downregulated genes related to neuroinflammation.	PMC8740777
C6 glioblastoma cells	1 µM	1 hour	Evaluate the selectivity of Ponesimod for S1PR internalization. Results showed Ponesimod only reduced cell surface expression of S1P1, while other S1PRs remained unchanged.	PMC8740777
Hela cells	100 nM	4 hours	To evaluate the ability of BSA–RuII(CO)2 complex to release CO in HeLa cells, results showed a significant increase in intracellular fluorescence indicating CO release.	PMC10393615
BV2 cells	10 nM or 100 nM	24 hours	SR9011 inhibited LPS-induced iNOS and COX-2 protein expression	PMC10393615
Primary microglia	100 nM	24 hours	Ponesimod enhanced phagocytosis of Aβ42 in microglia.	PMC10393615
Primary glial cells	10 nM or 100 nM	24 hours	Ponesimod prevented the Aβ42-induced increase in TLR4 and S1PR1 levels and their complex formation.	PMC10393615
HASTR/ci35 cells	1 μM	1 hour	To assess FTY720-induced CD320 internalization	PMC11066976
Human primary astrocytes	1 µM	1 hour	Evaluate the effect of Ponesimod on cytokine-induced gene expression changes. Results showed Ponesimod significantly downregulated genes related to neuroinflammation.	PMC8740777
C6 glioblastoma cells	1 µM	1 hour	Evaluate the selectivity of Ponesimod for S1PR internalization. Results showed Ponesimod only reduced cell surface expression of S1P1, while other S1PRs remained unchanged.	PMC8740777

5XFAD mice	Alzheimer's disease model	Oral gavage	30 mg/kg	Once daily for 4 weeks	Ponesimod reduced neuroinflammation, improved spatial memory, and decreased the number and size of amyloid plaques.	PMC10393615
C57BL/6J male mice	Cuprizone-induced demyelination model	Oral	30 mg/kg	Twice daily for 5–6 weeks	Evaluate the protective effect of Ponesimod against demyelination. Results showed Ponesimod selectively protected the cingulum from demyelination and increased oligodendrocyte numbers.	PMC8740777
5XFAD mice	Alzheimer's disease model	Oral gavage	30 mg/kg	Once daily for 4 weeks	Ponesimod reduced levels of neuroinflammatory markers (e.g., TNF-α and CXCL10), increased the anti-inflammatory cytokine IL-33, decreased activation of microglia and astrocytes, reduced amyloid plaque number and size, and improved spatial memory.	PMC10393615
Mice	Experimental autoimmune encephalomyelitis (EAE)	Oral gavage	1 mg/kg	Daily administration	To evaluate the efficacy of FTY720 in the EAE model	PMC11066976
C57BL/6J male mice	Cuprizone-induced demyelination model	Oral	30 mg/kg	Twice daily for 5-6 weeks	Evaluate the protective effect of Ponesimod on cuprizone-induced demyelination. Results showed Ponesimod selectively protected myelin in the cingulum, increased oligodendrocyte numbers, and reduced microglia and astrocytes.	PMC8740777

{[proInfo.proName]}

CAS No.: 854107-55-4

{[proInfo.proName]}

CAS No.: 854107-55-4

Alternative Products

Product Details of Ponesimod

Safety of Ponesimod

Related Pathways of Ponesimod

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT01208090	Psoriasis	Phase 2	Completed	-	-
NCT01006265	Multiple Sclerosis	Phase 2	Completed	-	-
NCT02223832	Healthy	PHASE1	COMPLETED	2025-04-09	Hawaii Clinical Research Cente... More >>r, Honolulu, Hawaii, 96813, United States Less <<
NCT02068235	Healthy	Phase 1	Completed	-	United Kingdom ... More >> Simbec Research Limited Merthyr Tydfil, United Kingdom, CF48 4DR Less <<
NCT02126956	Pharmacokinetics	PHASE1	COMPLETED	2025-04-09	Swiss Pharma Contract, Allschw... More >>il, Switzerland Less <<
NCT02029482	Safety and Tolerability	Phase 1	Completed	-	United Kingdom ... More >> Quintiles Drug Research Unit at Guyʼs Hospital London, United Kingdom, SE1 1YR Less <<
NCT02907177	Multiple Sclerosis	Phase 3	Recruiting	March 31, 2020	-
NCT01093326	Multiple Sclerosis	Phase 2	Active, not recruiting	December 15, 2021	-
NCT02425644	Multiple Sclerosis	Phase 3	Active, not recruiting	May 15, 2019	-
NCT03232073	Multiple Sclerosis	PHASE3	COMPLETED	2024-01-16	The Research Center of Souther... More >>n California, LLC, Carlsbad, California, 92011, United States\|The Neurology Group, Pomona, California, 91767, United States\|Mountain View Clinical Research, Denver, Colorado, 80209, United States\|Neurology Associates of Ormond Beach, Ormond Beach, Florida, 32174, United States\|University of South Florida, Tampa, Florida, 33612, United States\|Josephson Wallack Munshower Neurology, PC, Indianapolis, Indiana, 46256, United States\|Raleigh Neurology Associates, Raleigh, North Carolina, 27607, United States\|Ohio Health, Columbus, Ohio, 43214, United States\|Advanced Neurosciences Institute, Franklin, Tennessee, 37064, United States\|Grodno University Hospital, Grodno, 230017, Belarus\|Minsk City Clinical Hospital 5, Minsk, 220026, Belarus\|Republican Scientific Clinical Centre, Minsk, 220114, Belarus\|Vitebsk Regional Diagnostic Center, Vitebsk, 210023, Belarus\|Vitebsk Regional Clinical Hospital, Vitebsk, 210037, Belarus\|University Clinicl Center Sarajevo, Sarajevo, 71000, Bosnia and Herzegovina\|UMHAT Sveti Georgi, Plovdiv, 4002, Bulgaria\|Multiprofile Hospital for Active Treatment in Neurology and Psychiatry Sveti Naum, Sofia, 1113, Bulgaria\|Multiprofile Hospital For Active Treatment National Cardiology Hospital, Ead, Sofia, 1309, Bulgaria\|Acibadem City Clinic Tokuda Hospital, Sofia, 1407, Bulgaria\|St Ivan Rilski University Multiprofile Hospital For Active Treatment, Sofia, 1431, Bulgaria\|University Multiprofile Hospital for Active Treatment Alexandrovska EAD, Sofia, 1431, Bulgaria\|Military Medical Academy Multiprofile Hospital for Active Treatment Sofia, Sofia, 1606, Bulgaria\|University of Alberta, Edmonton, Alberta, T6G 1Z1, Canada\|Royal Jubilee Hospital, Victoria, British Columbia, V8R 1J8, Canada\|Ottawa Hospital, Ottawa, Ontario, K1H 8L6, Canada\|Recherche Sepmus Inc., Greenfield Park, Quebec, J4V 2J2, Canada\|Ch Osijek, Osijek, 31000, Croatia\|University Hospital Center Zagreb, Zagreb, 10000, Croatia\|Fakultní nemocnici Brno, Brno, 65691, Czechia\|Fakultni nemocnice Hradec Kralove, Hradec Králové, 500 05, Czechia\|Nemocnice Jihlava, Jihlava, 586 33, Czechia\|Fakultni Nemocnice Ostrava, Ostrava-Poruba, 708 52, Czechia\|Pardubicka krajska nemocnice a s, Pardubice, 532 03, Czechia\|Vseobecna Fakultní Nemocnice, Praha 2, 128 08, Czechia\|FN Motol, Praha 5, 150 06, Czechia\|Krajska zdravotni, a.s. - Nemocnice Teplice, o.z., Teplice, 415 29, Czechia\|Suomen Terveystalo Tampere, Tampere, 33100, Finland\|Mehilainen NEO, Turku, 20520, Finland\|Hopital Pellegrin CHU Bordeaux, Bordeaux cedex, 33076, France\|CHU Clermont-Ferrand - Hopital Gabriel Montpied, Clermont Ferrand Cedex 1, 63003, France\|Hopital Nord Laennec - CHU NANTES, Nantes Cedex 1, 44093, France\|Hopital PASTEUR, Nice, 6000, France\|Nouvel Hopital Civil, Strasbourg CEDEX, 67091, France\|LTD 'Aversi Clinic', T'bilisi, 0160, Georgia\|P. Sarajishvili Institute of Neurology, Tbilisi, 112, Georgia\|Pineo Medical Ecosystem Ltd, Tbilisi, 114, Georgia\|S.Khechinashvili University Hospital, Tbilisi, 179, Georgia\|Curatio, Jsc, Tbilisi, 186, Georgia\|Universit?tsklinikum Carl-Gustav-Carus Dresden, Dresden, 1307, Germany\|Helios Klinikum Erfurt, Erfurt, 99089, Germany\|Panakeia - Arzneimittelforschung GmbH, Leipzig, 04275, Germany\|Universitatsmedizin der Johannes Gutenberg Universitat Mainz, Mainz, 55131, Germany\|401 Military Hospital, Athens, 115 25, Greece\|Naval Hospital of Athens, Athens, 11521, Greece\|Medical Center of Athens, Marousi, 15125, Greece\|Uzsoki Utcai Korhaz, Budapest, 1145, Hungary\|Jahn Ferenc Del-pesti Korhaz es Rendelointezet, Budapest, 1204, Hungary\|Valeomed EGéSZSéGüGYI K?ZPONT, Esztergom, 2500, Hungary\|Petz Aladar Megyei Oktato Korhaz, Gy?r, 9023, Hungary\|Kistarcsai Flor Ferenc Korhaz, Kistarcsa, 2143, Hungary\|Barzilai Medical Center, Ashkelon, 7830604, Israel\|Rambam Medical Center, Haifa, 3109601, Israel\|Hadassah Medical Center, Jerusalem, 9112001, Israel\|Ziv Medical Center, Safed, 1304300, Israel\|Ospedale San Salvatore, L' Aquila, 67100, Italy\|Azienda Ospedaliera Sant Andrea, Roma, 189, Italy\|Pauls Stradins Clinical University Hospital, Riga, 1002, Latvia\|Latvias Juras medicinas centrs Ltd, Riga, 1015, Latvia\|Rīgas Austrumu klīniskā universitātes slimnīca, Riga, LV-1038, Latvia\|Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Kaunas, LT50161, Lithuania\|VsI Respublikine Siauliu ligonine, V., ?iauliai, 76231, Lithuania\|Unidad de Investigacion En Salud, Chihuahua, 31203, Mexico\|CRI Centro Regiomontano de Investigacion SC, Nuevo Leon, 64060, Mexico\|Neurocentrum Bydgoszcz Sp Z O O, Bydgoszcz, 85 796, Poland\|Copernicus Podmiot Leczniczy Sp. z o.o, Gdansk, 80-803, Poland\|Neuro Centrum Centrum Terapii SM, Katowice, 40 571, Poland\|NEURO MEDIC Janusz Zbrojkiewicz Poradnia Wielospecjalistyczna, Katowice, 40 686, Poland\|Centrum Kompleksowej Rehabilitacji, Konstancin Jeziorna, 05 510, Poland\|Centrum Opieki Zdrowotnej Orkan Med, Ksawerow, 95 054, Poland\|Indywidualna Praktyka Lekarska Prof. Konrad Rejdak, Lublin, 20-410, Poland\|Szpital Kliniczny im Heliodora Swiecickiego Uniwersytetu Medycznego im Karola Marcinkowskiego w Po, Poznan, 60 355, Poland\|Clinical Research Center sp z o o MEDIC R s k, Poznan, 61 731, Poland\|NZOZ NEURO KARD Ilkowski i Partnerzy Sp Partnerska Lekarzy, Poznan, 61 853, Poland\|WroMedica I Bielicka A Strzalkowska s c, Wroclaw, 51 685, Poland\|Hospital de Braga, Braga, 4710-243, Portugal\|Hospitais da universidade de Coimbra, Coimbra, 3000-075, Portugal\|Hosp. Cuf Descobertas, Lisboa, 1998-018, Portugal\|H. Santo António - Centro Hospitalar do Porto, Porto, 4099-001, Portugal\|Spitalul Universitar de Urgenta Militar Central 'Dr. Carol Davila', Bucuresti, 10825, Romania\|Institutul Clinic Fundeni, Bucuresti, 22328, Romania\|Spitalul Universitar de Urgenta Bucuresti, Bucuresti, 50098, Romania\|Spitalul Clinic Judetean de Urgenta Pius Brinzeu, Timisoara, 300723, Romania\|Barnaul Territorial Clinical Hospital, Barnaul, 656024, Russian Federation\|St. Joseph Belgorod Regional Hospital, Belgorod, 308007, Russian Federation\|Bryansk Regional Hospital #1, Bryansk, 241033, Russian Federation\|Sverdlovsk Region Clinical Hospital #1, Ekaterinburg, 620102, Russian Federation\|Research Medical Center Your Health, Kazan, 420097, Russian Federation\|Federal State Budgetary Institution, Krasnoyarsk, 660037, Russian Federation\|State Budgetary Healthcare Institution Kursk Region Kursk Regional Clinical Hospital, Kursk, 305007, Russian Federation\|Clinical City Hospital #1, Moscow, 117049, Russian Federation\|State Health Care Institution Of Moscow, Moscow, 127015, Russian Federation\|Central Clinical Hospital N.A.Semashko, Moscow, 129128, Russian Federation\|Municipal Clinical Hospital # 3, Nizhniy Novgorod, 603155, Russian Federation\|Siberian District Medical Center of Federal Medical-Biological Agency, Novosibirsk, 630007, Russian Federation\|Federal Scientific Clinical Center of Physico-Chemical Medicine, Odintsovo, 143000, Russian Federation\|Perm State Medical Academy n.a. E. A. Vagner, Perm, 614990, Russian Federation\|City Clinical Hospital # 2, Pyatigorsk, 357538, Russian Federation\|Pavlov First Saint Petersburg State Medical University, Saint Petersburg, 197022, Russian Federation\|State Healthcare Institution Samara Regional Clinical Hospital named after V.D.Seredavin, Samara, 443095, Russian Federation\|Smolensk Regional Clinical Hospital, Smolensk, 214018, Russian Federation\|Municipal Multi-Specialty Hospital # 2, St. Petersburg, 194354, Russian Federation\|City Clinical Hospital #31, St. Petersburg, 197110, Russian Federation\|Institute of Human Brain Ras, St. Petersburg, 197376, Russian Federation\|City Hospital# 40, St.Petersburg, 197706, Russian Federation\|Siberian State Medical University, Tomsk, 634050, Russian Federation\|Tver Regional Clinical Hospital, Tver, 170036, Russian Federation\|GUZ Novgorod Regional Clinical Hospital, Velikiy Novgorod, 214018, Russian Federation\|Yaroslavl Clinical Hospital #8, Yaroslavl, 150003, Russian Federation\|Clinical Hospital Center Zvezdara, Belgrade, 11000, Serbia\|Vojnomedicinska Akademija, Belgrade, 11000, Serbia\|University Clinical Center Kragujevac, Kragujevac, 34000, Serbia\|University Clinical Center NIS, Nis, 18000, Serbia\|Hospital del Mar, Barcelona, 8003, Spain\|Hospital Vall d'Hebron, Barcelona, 8035, Spain\|Hospital Clinic I Provincial, Barcelona, 8036, Spain\|Hospital Universitario de La Princesa, Madrid, 28006, Spain\|Hospital Regional Universitario de Malaga, Malaga, 29010, Spain\|Hospital Universitario Virgen Macarena, Sevilla, 41009, Spain\|Hospital Vithas Nisa Sevilla, Sevilla, 41950, Spain\|Sahlgrenska Universitetsjukhuset, G?teborg, 413 45, Sweden\|Centrum f?r Neurologi, Stockholm, 113 65, Sweden\|Karadeniz Teknik University Medical Faculty, Trabzon, 61080, Turkey\|Public Non-profit Enterprise: Chernihiv City Hospital #4 under Chernihiv City Council, Chernihiv, 14001, Ukraine\|Municipal health care institution Chernihiv Regional Hospital, Chernihiv, 14029, Ukraine\|Ivano-Frankivsk Regional Clinical Hospital, Ivano-Frankivsk, 76018, Ukraine\|Limited Liability Company 'Neuro Global', Ivano-Frankivsk, 76493, Ukraine\|Kharkiv Railway Clinical Hospital N1 Of Brance 'Health Center', Kharkiv, 61103, Ukraine\|Kharkiv Postgrad Academy, Dept of Neurology #1 At Hosp #7, Kharkiv, 61176, Ukraine\|National Research Center for Radiation Medicine, Kyiv, 3115, Ukraine\|Public Non-Profit Enterprise: Lviv City Clinical Hospital #5, Lviv, 79000, Ukraine\|Lviv Clinical Regional Hospital, Lviv, 79010, Ukraine\|Odessa National Medical University, Odesa, 65009, Ukraine\|ME 'Poltava Regional Clinical Hospital n.a. M.V. Sklifosovsky of the Poltava Regional Council', Poltava, 36024, Ukraine\|Mnce 'Ternopil Regional Clinical Psychoneurology Hospital' of Trb, Ternopil, 46027, Ukraine\|Medical Center Salutem LLC, Vinnytsia, 21000, Ukraine\|O.F. Herbachevskyi Regional Clinical Hospital, Zhytomyr, 10008, Ukraine\|Royal Preston Hospital, Preston, PR2 9HT, United Kingdom\|Salford Royal NHS Foundation Trust, Salford, M6 8HD, United Kingdom Less <<
NCT00852670	Plaque Psoriasis	Phase 2	Completed	-	Austria ... More >> Landeskrankenhaus - Universitätsklilnikum Graz, Allgemeine Dermatologie Graz, Austria, 8036 University Klinik of Vienna Vienna, Austria, 1090 France Departement de Pneumologie/ Unité Immunologie Clinique Allergie- Centre Hospitalier Lyon sud Lyon, France, 69000 CHU de Nice-Hôpital de l'Archet 2 / Service de dermatologie Nice, France, 6202 Dermatologie, Hôpital Purpan Universtité Paul Sabatier Toulouse, France, 31000 Germany Klinik für Dermatologie Venerologie und Allergologie Berlin, Germany, 10117 Universitätsklinikum Hamburg-Eppendorf Hamburg, Germany, 20246 Department of Dermatology University Hospital Johannes Gutenberg-University Mainz Mainz, Germany, 55131 University Clinic Münster Clinic and Policlinic for skin diseases Muenster, Germany, 48149 Hungary Semmelweis Universtity Dept. dermato-venerology and skin oncology Budapest, Hungary, 1085 UNIVERSITY OF DEBRECEN Department of dermatology Debrecen, Hungary, 4012 University of Szeged Department of dermatology and allergology Szeged, Hungary, 6720 Veszprem County Csolnoky Ferenc Hospital Dermatology Department Veszprem, Hungary, 8200 Serbia Clinical Centre of Nis Clinic of Dermato-venerology Nis, Serbia, 18000 Less <<
NCT02136888	Healthy	Phase 1	Completed	-	United States, Indiana ... More >> Covance Clinical Research Unit (CRU) Evansville, Indiana, United States, 47710 Less <<
NCT02461134	Chronic Graft Versus Host Dise... More >>ase Less <<	PHASE2	TERMINATED	2017-03-03	-
NCT02461134	Chronic Graft Versus Host Dise... More >>ase Less <<	PHASE2	TERMINATED	2017-03-03	-

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	2.17mL 0.43mL 0.22mL	10.85mL 2.17mL 1.08mL	21.69mL 4.34mL 2.17mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1 Protocol 2

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed